TABLE 2.
Biompendance analysis parameters.
Baseline |
12-month follow-up |
24-month follow-up |
|||||||
Active patients | Inactive patients | P | Active patient | Inactive patients | P | Active patient | Inactive patients | P | |
N = 24 (49%) | N = 25 (51%) | N = 19 (49%) | N = 20 (51%) | N = 10 (35%) | N = 19 (65%) | ||||
Body weight (Kg) | 69.9 ± 18.4 | 69.2 ± 14.7 | 0.88 | 66.6 ± 18.0 | 71.2 ± 13.7 | 0.38 | 62.25 ± 13.8 | 73.65 ± 16.9 | 0.07 |
Biompendance analysis | |||||||||
Fat mass | |||||||||
(%) | 33.2 ± 8.9 | 31.6 ± 8.0 | 0.52 | 30.3 ± 8.2 | 30.5 ± 6.9 | 0.94 | 32.4 ± 9.1 | 32.7 ± 7.4 | 0.98 |
(kg) | 23.3 ± 9.2 | 21.0 ± 7.2 | 0.58 | 20.35 ± 8.07 | 20.83 ± 7.87 | 0.85 | 20.37 ± 7.54 | 24.2 ± 8.12 | 0.21 |
Intracellular water (%) | 51.2 ± 7.3 | 44.5 ± 9.5 | 0.008 | 52.4 ± 5.98 | 43.1 ± 9.4 | 0.001 | 53.1 ± 5.97 | 45.4 ± 7.7 | 0.012 |
Cellular mass (%) | 42.3 ± 7.3 | 35.9 ± 7.8 | 0.005 | 43.1 ± 4.02 | 33.04 ± 9.4 | <0.001 | 43.08 ± 4.2 | 35.9 ± 6.3 | 0.002 |
Body mass cell index (kg/m2) | 6.7 ± 1.9 | 5.6 ± 1.8 | 0.04 | 6.88 ± 1.9 | 5.65 ± 1.9 | 0.059 | 6.18 ± 1.72 | 6.95 ± 4.2 | 0.58 |
Phase angle (°) | 5.2 ± 1.2 | 4.1 ± 1.1 | <0.001 | 5.2 ± 1.0 | 4.0 ± 1.1 | <0.001 | 5.4 ± 1.1 | 4.3 ± 1.2 | 0.02 |